ClinicalTrials.Veeva

Menu

Radiomics-based Non-invasive Classifier Research for HCC-related Liver Transplantation

Zhejiang University logo

Zhejiang University

Status

Unknown

Conditions

Liver Transplantation
Hepatocellular Carcinoma
Magnetic Resonance Imaging

Treatments

Other: Risk model of tumor relapse

Study type

Observational

Funder types

Other

Identifiers

NCT03981848
2019ZJUXX-001

Details and patient eligibility

About

The purpose of this study is to establish a non-invasive radiomics method to filter high recurrent-risk liver transplantation recipient population

Full description

Hepatocellular carcinoma is one of the most common malignant tumors in the world with high incidence and mortality. Liver transplantation is the most effective treatment for HCC and is in high demand in China. However, recurrence of HCC among liver transplantation recipients is still a great challenge and threat to the survival of recipients. So it is of great significance to establish a non-invasive way to filter high liver transplantation recipient population before transplantation. Based on large scales of pre-treatment MR images, the investigator's study aims to establish a non-invasive radiomics method to filter high recurrent-risk liver transplantation recipient population. This study will contribute to the precise selection of HCC-related liver transplantation recipients.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients had postoperative pathological diagnosis of HCC
  • All patients had underwent contrast-enhanced MRI scan within 2 weeks before liver transplantation

Exclusion criteria

  • patients whose pathological diagnosis is not HCC
  • patients whose CT images were affected by strong imaging artifacts, i.e. artifacts obscuring more than 10% of whole volume of interest
  • patients whose clinical data or CT images were missing

Trial design

200 participants in 2 patient groups

Relapse
Description:
Relapse of tumor within two years after liver transplantation
Treatment:
Other: Risk model of tumor relapse
Non-relapse
Description:
Non-relapse of tumor within two years after liver transplantation
Treatment:
Other: Risk model of tumor relapse

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems